BVF »

Engene Holdings shares owned by BVF

Quarter-by-quarter ownership of Engene Holdings (ENGNW) shares owned by BVF from 13F filings

Historical chart of BVF investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by BVF

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3M 945k 1.39
2024-03-31 $4.9M 945k 5.20
2023-12-31 $804k 945k 0.85

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Ionis Pharmaceuticals (IONS)
Mirum Pharmaceuticals (MIRM)
Gh Research Ordinary Shares (GHRS)
Protagonist Therapeutics (PTGX)
Cullinan Oncology (CGEM)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Sponsored Ads (GPCR)
Xoma Corp Del Com New (XOMA)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Axsome Therapeutics (AXSM)
Cg Oncology (CGON)

View all positions for BVF

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
BVF
Omega Fund Management
Saba Capital Management
Calamos Advisors
D. E. Shaw & Co
Polar Securities
Millennium Management
Tenor Capital Management
Blue Owl Capital Holdings
Whitebox Advisors
Wolverine Asset Management
CSS
Marshall Wace
Bank of America Corporation

View all funds holding Engene Holdings